Daily Anesthesiology Research Analysis
Three studies reshape perioperative management in anesthesiology and critical care. A target trial emulation suggests an early, time-limited survival benefit of liberal transfusion thresholds in VA-ECMO; a meta-analysis shows hypotension prediction index–guided care reduces intraoperative hypotension and major complications; and an individual patient–data analysis links intraoperative chemical and mechanical power to postoperative pulmonary complications, underscoring oxygen and ventilation ener
Summary
Three studies reshape perioperative management in anesthesiology and critical care. A target trial emulation suggests an early, time-limited survival benefit of liberal transfusion thresholds in VA-ECMO; a meta-analysis shows hypotension prediction index–guided care reduces intraoperative hypotension and major complications; and an individual patient–data analysis links intraoperative chemical and mechanical power to postoperative pulmonary complications, underscoring oxygen and ventilation energy stewardship.
Research Themes
- Time-sensitive transfusion strategies in VA-ECMO via target trial emulation
- Predictive hemodynamic monitoring to prevent intraoperative hypotension and complications
- Ventilation and oxygen energy stewardship to reduce postoperative pulmonary complications
Selected Articles
1. Liberal or restrictive transfusion for veno-arterial extracorporeal membrane oxygenation patients: a target trial emulation using the OBLEX study data.
In a target trial emulation of 534 VA-ECMO patients, initiating transfusion at Hb ≥ 90 g/L conferred a modest survival advantage during days 2–3 after ECMO initiation (absolute survival differences 12–13%; NNT 8–7), with no benefit beyond day 3. Findings were robust across sensitivity analyses and highlight time-dependent transfusion effects.
Impact: Challenges a one-size-fits-all restrictive transfusion approach by identifying an early window during VA-ECMO when liberal thresholds may improve survival. Uses modern causal inference to inform practice where RCTs are scarce.
Clinical Implications: Consider a time-limited, more liberal transfusion threshold during the first 48–72 hours of VA-ECMO while awaiting definitive RCTs, with vigilant reassessment thereafter. Incorporate patient bleeding risk and hemodynamics into individualized transfusion decisions.
Key Findings
- Liberal transfusion (Hb ≥ 90 g/L) improved survival probabilities at day 2 (absolute +12%, 95% CI 3–21%) and day 3 (absolute +13%, 95% CI 2–25%).
- No survival difference between liberal and restrictive strategies after day 3 of VA-ECMO.
- Results were consistent across sensitivity and exploratory analyses using a sequential trials approach.
Methodological Strengths
- Target trial emulation with sequential trials framework on multicenter prospective data.
- Adjustment for measured confounders with robust sensitivity analyses.
Limitations
- Observational emulation cannot eliminate residual confounding or unmeasured biases.
- Benefit limited to early days; generalizability to all VA-ECMO indications and protocols may vary.
Future Directions: Randomized trials testing dynamic, time-dependent transfusion thresholds in VA-ECMO; mechanistic studies on oxygen delivery, hemolysis, and microcirculatory effects during early ECMO.
BACKGROUND: The optimal transfusion threshold for patients undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO) remains uncertain. METHODS: We used data from OBLEX (ClinicalTrials.gov: NCT03714048), an international, prospective, observational study conducted across 12 centres in Australia, Europe, and North America between 2019 and 2022. The study collected information on patient demographics, bleeding risk factors, transfusion practices during the first seven days of ECMO, and in-hospital mortality. Using these data, we emulated a target trial comparing the effects of liberal transfusion practice (transfusion initiated at Hb ≥ 90 g/L) and restrictive transfusion practice (transfusion initiated at Hb ≤ 70 g/L) on hospital mortality within seven days of ECMO initiation. Sequential trials approach was used to estimate the causal contrast. RESULTS: A total of 534 patients were included, with 46% dying during hospitalisation. After accounting for potential confounders, the liberal transfusion practice demonstrated a modest survival benefit within the first two days of ECMO, with differences in survival probabilities of 12% (95% CI 3% to 21%) at day 2 and 13% (95% CI 2% to 25%) at day 3, corresponding to the number needed to treat (NNT) of 8 and 7 respectively. No differences in survival benefit were found after day 3. These results were consistent across sensitivity and exploratory analyses. CONCLUSION: This target trial emulation study suggests that a liberal transfusion threshold may provide a modest survival benefit during the early course of VA-ECMO, but no benefit afterwards. Prospective studies are needed to confirm these findings, assess clinical adoption, and investigate underlying mechanism.
2. Hypotension prediction index in the prediction of better outcomes: a systemic review and meta-analysis.
Across 19 studies (12 RCTs; n=2,570), HPI-guided hemodynamic management reduced intraoperative hypotension and major complications (RR 0.79, 95% CI 0.69–0.90) without increasing blood loss or length of stay. Study quality was generally high with low risk of bias in RCTs.
Impact: Synthesizes randomized and observational evidence to show that predictive, protocolized management using HPI improves clinically meaningful outcomes, supporting broader implementation in perioperative care.
Clinical Implications: Adopt HPI-guided protocols with predefined corrective actions to proactively prevent hypotension and reduce major complications, integrating device alerts into anesthesia workflows and quality programs.
Key Findings
- HPI-guided management reduced major complications and intraoperative hypotension (RR 0.79, 95% CI 0.69–0.90; P=0.0005).
- No significant differences in blood loss or hospital length of stay between HPI-guided and control groups.
- Included 12 RCTs and 7 high-quality retrospective studies (total n=2,570) with low risk of bias in RCTs.
Methodological Strengths
- PRISMA- and Cochrane-guided systematic review with meta-analysis across randomized and observational designs.
- Low heterogeneity (I2=0) for primary outcome and formal assessment of bias.
Limitations
- Variability in HPI versions, alert thresholds, and response protocols across studies.
- Mixture of RCTs and retrospective designs; potential publication bias cannot be fully excluded.
Future Directions: Pragmatic multicenter RCTs testing standardized HPI response bundles on patient-centered outcomes; cost-effectiveness and implementation science studies across diverse hospitals.
BACKGROUND: The hypotension prediction index (HPI) is an algorithm designed to predict hypotension. Some studies have reported that HPI-guided hemodynamic management strategies decrease intraoperative hypotension and complications; however, the effect of HPI on reducing perioperative complications are controversial. This meta-analysis aimed to assess the efficacy of the HPI in reducing major complications and intraoperative hypotension. METHODS: We conducted this meta-analysis according to the PRISMA statement and Cochrane Handbook guidelines. A comprehensive literature review was conducted to identify studies focusing on the efficacy of HPI-guided management in reducing intraoperative hypotension and postoperative complications. The PubMed, Embase, Scopus, and Web of Science databases were searched, and the resulting data were combined to calculate the pooled mean differences (MDs) or risk ratios (RRs) with 95% CIs of both randomized controlled trials (RCTs) and retrospective studies, as appropriate. Heterogeneity and potential publication bias were also assessed. RESULTS: Nineteen articles (12 RCTs and 7 retrospective studies) with 2,570 recruited patients were included in this meta-analysis. The critical evaluation of the study quality revealed a low risk of bias in the included RCTs. Among the non-randomized trials, one was rated 7, two were rated 8, and the remaining four were rated 9 on the Newcastle-Ottawa Scale, indicating high quality and a low risk of bias. HPI-guided management significantly reduced intraoperative hypotension and associated major complications (RR = 0.79, 95% CI [0.69, 0.90], I2 = 0; P = 0.0005). Blood loss and length of hospital stay were comparable between the groups. CONCLUSIONS: HPI-guided management significantly reduced intraoperative hypotension and major complications.
3. Individual and combined effects of chemical and mechanical power on postoperative pulmonary complications: a secondary analysis of the REPEAT study.
In an individual patient–data analysis of 2,492 surgical patients from three ventilation RCTs, higher intraoperative chemical power (oxygen exposure) and mechanical power (ventilatory energy) were independently associated with increased postoperative pulmonary complications. Each small increment corresponded to approximately 8% (chemical) and 5% (mechanical) higher odds, without evidence of interaction.
Impact: Bridges mechanistic physiology with clinical outcomes by quantifying oxygen and ventilation energy loads and linking them to postoperative pulmonary complications, informing oxygen and ventilation stewardship.
Clinical Implications: Avoid excessive FiO2 and minimize mechanical power (e.g., optimize tidal volume, driving pressure, and respiratory rate) during anesthesia to reduce pulmonary complications; integrate power metrics into intraoperative monitoring and quality initiatives.
Key Findings
- Both higher chemical power (oxygen exposure) and mechanical power were independently associated with increased postoperative pulmonary complications.
- Per small increment, chemical power increased risk by ~8% and mechanical power by ~5%.
- No significant interaction between chemical and mechanical power was observed.
Methodological Strengths
- Individual patient–data analysis from three randomized ventilation trials with time-weighted exposure metrics.
- Multivariable adjustment assessing independent and combined effects.
Limitations
- Secondary analysis; causality cannot be established.
- Incomplete reporting of exact effect sizes per unit increase in the primary abstract; external validation needed.
Future Directions: Prospective trials testing oxygen- and power-sparing intraoperative strategies on pulmonary complications; development of real-time power monitoring and decision support.
INTRODUCTION: Intra-operative supplemental oxygen and mechanical ventilation expose the lungs to potentially injurious energy. This can be quantified as 'chemical power' and 'mechanical power', respectively. In this study, we sought to determine if intra-operative chemical and mechanical power, individually and/or in combination, are associated with postoperative pulmonary complications. METHODS: Using an individual patient data analysis of three randomised clinical trials of intra-operative ventilation, we summarised intra-operative chemical and mechanical power using time-weighted averages. We evaluated the association between intra-operative chemical and mechanical power and a collapsed composite of postoperative pulmonary complications using multivariable logistic regression to estimate the odds ratios related to the effect of 1 J.min RESULTS: Of 3837 patients recruited to three individual trials, 2492 with full datasets were included in the analysis. Intra-operative time-weighted average (SD) chemical power was 10.2 (3.9) J.min DISCUSSION: Both chemical and mechanical power are independently associated with postoperative pulmonary complications. Further work is required to determine causality. When people have surgery, they often need extra oxygen and a machine to help them breathe. But this can sometimes put stress on the lungs and cause problems afterward. In this study, doctors wanted to see if the amount of energy used by the oxygen and the breathing machine (called ‘chemical power’ and ‘mechanical power’) could be linked to lung problems after surgery. Doctors looked at data from three big studies involving patients who had surgery with breathing support. They measured how much chemical and mechanical power was used during surgery and averaged it over time. Then, they checked to see if people who had more of this power used during surgery were more likely to have breathing or lung problems afterward. They also checked if using both types of power together made things worse. Out of 3837 patients, 2492 had complete information and were included in the study. On average, the chemical power used was about 10.2 and the mechanical power was about 10.5 (measured in special units called Joules per minute). For every small increase in chemical power, the chance of lung problems after surgery went up by 8%. For the same increase in mechanical power, the chance went up by 5%. The two types of power didn't seem to make each other worse when used together. The study showed that both chemical and mechanical power during surgery can raise the risk of lung problems afterward. More research is needed to understand if one causes the other, or if something else is going on.